I G Popovich
Overview
Explore the profile of I G Popovich including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
205
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ilina A, Popovich I, Ryzhak G, Khavinson V
Adv Gerontol
. 2024 Jun;
37(1-2):10-20.
PMID: 38944767
Alzheimer's disease (AD) is the most common neurodegenerative disorder, characterized by progressive cognitive decline. This review discusses current therapeutic strategies for the treatment of Alzheimer's disease, their limitations, and potential...
2.
Mironova E, Linkova N, Popovich I, Kozina L, Khavinson V
Adv Gerontol
. 2020 Jun;
33(2):299-306.
PMID: 32593244
Neurodegenerative diseases are a heterogeneous group of nervous system pathologies. They are found mainly in people of an older age group. The incidence of neurodegenerative diseases is continuously growing due...
3.
Yurova M, Tyndyk M, Popovich I, Golubev A, Anisimov V
Adv Gerontol
. 2019 Jun;
32(1-2):66-75.
PMID: 31228370
Melatonin was administered at the dose of 1,2 mcg per capita (an equivalent to pediatric dosages) at days 1, 3 and 5 postpartum to 129/Sv mice, which were followed thereafter...
4.
Anisimov V, Popovich I, Egormin P, Tyndyk M, Yurova M, Osipov M
Vopr Onkol
. 2018 Nov;
62(2):234-44.
PMID: 30452215
The critical analysis of preclinical testing of anticarcinogenic and antitumor activity of biguanides presented in this paper. Experiments have been conducted using in total more than 20 models of carcinogenesis...
5.
Osipov M, Anismov V, Popovich I, Semiglazova T
Vopr Onkol
. 2018 Nov;
62(1):146-9.
PMID: 30444593
A combined antitumor effect of a single injection of doxorubicin and the indole hormone melatonin was investigated in the model of transplantable Ehrlich carcinoma in female SHR mice. Animals received...
6.
Trashkov A, Panchenko A, Korablev R, Yurova M, Egormin P, Chernenko N, et al.
Vopr Onkol
. 2015 Nov;
61(4):642-6.
PMID: 26571837
Age-dependent angiogenesis intensity changes have been studied in transgenic HER-2/neu (FBV/N) mice characteristic of breast tumors' high incidence with hyperexpression of HER-2/neu. Concentration of vascular endothelial growth factor, insulin-dependent growth...
7.
Anikin I, Goncharov N, Tyndyk M, Voishenko N, Pliss G, Zabezhinskii M, et al.
Vopr Onkol
. 2015 Jan;
60(4):514-6.
PMID: 25552075
Previously it was found that sodium fluoroacetate (SF) inhibited the growth of the Ehrlich cancer by means of monotherapy and enhanced the antitumor effect of cyclophosphamide (CP) in experiments with...
8.
Anisimov V, Vinogradova I, Bukalev A, Popovich I, Zabezhinskii M, Panchenko A, et al.
Vopr Onkol
. 2014 Jun;
60(2):15-27.
PMID: 24919257
There were obtained sufficient experimental evidence of the stimulating effect on the development of tumors (transplanted, spontaneous and induced by various carcinogenic agents), disorders of circadian function of the pineal...
9.
Anikin I, Tyndyk M, Zabezhinskii M, Popovich I, Anisimov V, Pliss G
Vopr Onkol
. 2014 Apr;
60(1):94-5.
PMID: 24772624
Antifibrinolytic drug epsilon-aminocaproic acid as a therapeutic form (5% solution in saline) was tested for antitumor activity in the autochthonous subcutaneous tumors of mice, induced by benzo (a) pyrene, in...
10.
Anikin I, Goncharov N, Tyndyk M, Voitenko N, Pliss G, Zabezhinskii M, et al.
Vopr Onkol
. 2014 Mar;
59(6):777-80.
PMID: 24624791
Due to biochemical characteristics of toxic action of fluoroacetate on energetics and metabolism of cells, including tumor cells, it was interesting to testify sodium fluoroacetate (SFA) for its antitumor activity...